10-Year watch: does a common eczema cream pose a cancer risk to kids?
NCT ID NCT00568997
Summary
This is a long-term safety study, not a treatment trial. Researchers are observing 8,000 children and teens with eczema who have already used Elidel cream. The goal is to track them for 10 years to see if using this common eczema medication is linked to any increased risk of developing cancer.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATOPIC DERMATITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Registry
Philadelphia, Pennsylvania, 19104, United States
Conditions
Explore the condition pages connected to this study.